TRZ40MG/RETA20MG =60MG

TRZ40MG/RETA20MG (60MG) is a premium research peptide blend containing 40 mg of Tirzepatide and 20 mg of Retatrutide. This combination has been developed for laboratory investigations focused on metabolic regulation, glucose metabolism, appetite signaling, insulin response, and energy balance. Manufactured under strict quality control standards, this research formulation provides consistent purity and reliability for scientific applications.

Tirzepatide is a dual receptor agonist that targets GLP-1 and GIP receptors. It is widely studied for its potential effects on glucose regulation, insulin sensitivity, appetite control, and metabolic function.

Retatrutide is an investigational triple receptor agonist that activates GLP-1, GIP, and glucagon receptors. It is currently being researched for its potential role in energy expenditure, fat metabolism, appetite regulation, delayed gastric emptying, and overall metabolic balance. Its additional glucagon receptor activity distinguishes it from conventional GLP-1 receptor agonists and has made it an important subject in obesity and metabolic research.

This combination offers researchers the opportunity to investigate the complementary mechanisms of two advanced metabolic peptides within a single formulation.

• 40 mg Tirzepatide + 20 mg Retatrutide
• Total Peptide Content: 60 mg
• High Purity Research Grade
• Manufactured Under Strict Quality Control Standards
• Secure Packaging
• Designed for Laboratory and Scientific Research
• For Research Use Only

Storage:
Store in a cool, dry environment away from direct sunlight. Refrigerate after reconstitution according to established laboratory protocols.

Disclaimer:
This product is intended strictly for laboratory research purposes only. It is not intended for human consumption, veterinary use, therapeutic applications, or diagnostic procedures. Use only by qualified research professionals in appropriate laboratory settings.